A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers
Novartis
Novartis
MacroGenics
Guardant Health, Inc.
Toray Industries, Inc
Medicenna Therapeutics, Inc.
Theratechnologies
University Health Network, Toronto
Stanford University
Salubris Biotherapeutics Inc
Eli Lilly and Company
BioEclipse Therapeutics
Xencor, Inc.
Ohio State University Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Abramson Cancer Center at Penn Medicine
Vanderbilt-Ingram Cancer Center
City of Hope Medical Center
Swiss Cancer Institute
National Cancer Institute (NCI)
Vanderbilt-Ingram Cancer Center
Wake Forest University Health Sciences
Wake Forest University Health Sciences
Fred Hutchinson Cancer Center
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
University of Louisville
OHSU Knight Cancer Institute
Fred Hutchinson Cancer Center
Rutgers, The State University of New Jersey
University of Southern California
Barbara Ann Karmanos Cancer Institute
City of Hope Medical Center
National Cancer Institute (NCI)
Indiana University
University of Minnesota
Mayo Clinic
INSYS Therapeutics Inc
Rutgers, The State University of New Jersey
National Cancer Institute (NCI)
European Organisation for Research and Treatment of Cancer - EORTC
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
European Organisation for Research and Treatment of Cancer - EORTC